AVTX's logo.
Ticker Symbol: AVTX

Avalo Therapeutics Inc

$2.23 - 04-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001534120

Company Profile

cerecor inc. is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human brain. we are a delaware corporation, organized in april 2011 in partnership with various laboratories and research institutes at johns hopkins medical institute ("jhmi"). cerecor is focused on translational medicine – the accelerated transfer of technology from the academic laboratory to early human trials, with the goal of rapid commercialization. we acquire rights to early stage therapeutic technologies ("assets") from universities, finance and manage the development of these assets into drug candidates (to first major milestone or value inflection point) and then either commercialize or outlicense the asset.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 540 Gaither Rd Ste 400
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.12
Change: $0.00 ( -2.31%)
Days Range: $0.12 - $0.13
Beta: 0.45
52wk. High: $7.00
52wk. Low: $0.08
Ytd. Change -99.87%
50 Day Moving Average: $0.13
200 Day Moving Average: $1.35
Shares Outstanding: 20249447

Valuation

Market Cap: 2.4B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A